Pharma Mar, S.A. (OTCMKTS:PHMMF) Short Interest Down 47.8% in September

Pharma Mar, S.A. (OTCMKTS:PHMMF) was the recipient of a large decrease in short interest in September. As of September 30th, there was short interest totalling 17,800 shares, a decrease of 47.8% from the September 15th total of 34,100 shares. Based on an average daily trading volume, of 100 shares, the days-to-cover ratio is presently 178.0 days.

Wall Street Analysts Forecast Growth

Separately, Chardan Capital upgraded Pharma Mar to a “strong-buy” rating in a research report on Thursday, August 1st.

Pharma Mar Stock Performance

OTCMKTS:PHMMF remained flat at $52.54 during midday trading on Friday. The company’s 50 day moving average price is $42.83 and its 200 day moving average price is $35.17. Pharma Mar has a fifty-two week low of $26.85 and a fifty-two week high of $54.00.

About Pharma Mar

Pharma Mar, SA, a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles of marine origin for use in oncology in Spain, Italy, Germany, Ireland, France, rest of EU, the United States, and internationally. The company operates through Oncology and RNA interference segments.